Consistent with this suggestion, no effects of metformin were shown in the study of Yu et al. They observed the effects of insulin-stimulated peripheral glucose metabolism on T2D patients rendered normoglycemic following 4 weeks of continuous subcutaneous insulin, who received metformin (850 mg twice/day) treatment [43]. The gene discussed is INS; the disease is type 2 diabetes mellitus.